Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Lung Neoplasms 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cisplatin 3Taxes 2Psychiatric Rehabilitation 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Etoposide 2rubitecan 1pembrolizumab 1monalizumab 1marimastat 1etoposide phosphate 1durvalumab 1ceralasertib 1carfilzomib 1atezolizumab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Platinum Compounds 1PM 01183 1Nivolumab 1NK Cell Lectin-Like Receptor Subfamily C 1Mental Status and Dementia Tests 1Isotretinoin 1Irinotecan 1Ipilimumab 1Introns 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Small Cell Lung Carcinoma × Introns × Clear all
NCT00062010 2023-07-07

Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
37 enrolled 8 charts
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡